PET/CT Scan with not yet determined radiation dose for Positron Emission Tomography/Computed Tomography Imaging

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The Ohio State University Wexner Medical Center, Columbus, OHPositron Emission Tomography/Computed Tomography ImagingPET/CT Scan with not yet determined radiation dose - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing new, low-dose radiation techniques for PET/CT scans.

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: through study completion, on average 2-5 years

Year 5
Artifacts
Image noise
Image quality
Lesion detectability

Trial Safety

Trial Design

6 Treatment Groups

Sub-Study D
1 of 6
Sub-Study E
1 of 6
Sub-Study F
1 of 6
Sub-Study C
1 of 6
Sub-Study B
1 of 6
Sub-Study A
1 of 6

Experimental Treatment

190 Total Participants · 6 Treatment Groups

Primary Treatment: PET/CT Scan with not yet determined radiation dose · No Placebo Group · N/A

Sub-Study DExperimental Group · 2 Interventions: PET/CT scan with 13 mCi radiation dose, PET/CT scan with 5 mCi radiation dose · Intervention Types: DiagnosticTest, DiagnosticTest
Sub-Study EExperimental Group · 2 Interventions: PET/CT scan with 2.5 mCi radiation dose, PET/CT Scan with 6.5 mCi radiation dose · Intervention Types: DiagnosticTest, DiagnosticTest
Sub-Study FExperimental Group · 2 Interventions: PET/CT scan with 13 mCi radiation dose, PET/CT Scan with not yet determined radiation dose · Intervention Types: DiagnosticTest, DiagnosticTest
Sub-Study CExperimental Group · 2 Interventions: PET/CT scan with 13 mCi radiation dose, PET/CT scan with 5 mCi radiation dose · Intervention Types: DiagnosticTest, DiagnosticTest
Sub-Study BExperimental Group · 2 Interventions: PET/CT scan with 13 mCi radiation dose, PET/CT scan with 5 mCi radiation dose · Intervention Types: DiagnosticTest, DiagnosticTest
Sub-Study AExperimental Group · 2 Interventions: PET/CT scan with 13 mCi radiation dose, PET/CT scan with 5 mCi radiation dose · Intervention Types: DiagnosticTest, DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, on average 2-5 years

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
728 Previous Clinical Trials
458,849 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,153 Previous Clinical Trials
41,162,734 Total Patients Enrolled
Ohio Third FrontierOTHER
5 Previous Clinical Trials
501 Total Patients Enrolled
Michael V Knopp, MD, PhDPrincipal InvestigatorOhio State University
8 Previous Clinical Trials
314 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there opportunities to participate in this research endeavor?

"Affirmative. As per the clinicaltrials.gov website, this study is actively scouting for participants and was originally advertised on July 21st 2015 before being updated most recently on April 15th 2022. The research requires 204 volunteers to be recruited from 1 site." - Anonymous Online Contributor

Unverified Answer

How many participants are being trialed for this therapeutic intervention?

"Affirmative. The data posted to clinicaltrials.gov clarifies that this research project, initially listed on July 21st 2015, is still recruiting patients for participation. In total, 204 individuals are needed from a single medical site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.